JPS57126420A - Drug for digestive organ - Google Patents

Drug for digestive organ

Info

Publication number
JPS57126420A
JPS57126420A JP1065481A JP1065481A JPS57126420A JP S57126420 A JPS57126420 A JP S57126420A JP 1065481 A JP1065481 A JP 1065481A JP 1065481 A JP1065481 A JP 1065481A JP S57126420 A JPS57126420 A JP S57126420A
Authority
JP
Japan
Prior art keywords
carnitine
drug
acyl
effective
active constituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1065481A
Other languages
Japanese (ja)
Other versions
JPH0340010B2 (en
Inventor
Eiji Murakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP1065481A priority Critical patent/JPS57126420A/en
Publication of JPS57126420A publication Critical patent/JPS57126420A/en
Priority to JP41814490A priority patent/JPH03246221A/en
Publication of JPH0340010B2 publication Critical patent/JPH0340010B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: A drug for digestive organs, containing carnitine or a derivative thereof as an active constituent, and effective for preventing and treating anorexia, weight increase disorder, etc.
CONSTITUTION: A drug for digestive organs, containing at least one selected from d-carnitine, l-carnitine, acyl-d-carnitine, acyl-dl-carnitine, acyl-l-carnitine and a physiologically acceptable salt thereof as an active constituent. The carnitine is distributed in organisms widely ranging from men to microorganisms, and contained in a muscle or pancreatic juice in a large amount. The drug is administered most preferably orally, and the daily dose thereof is 5W100mg per adult divided in about 3 fractions. The drug is effective for promoting the appetite and increasing the body weight with low toxicity and no side effects.
COPYRIGHT: (C)1982,JPO&Japio
JP1065481A 1981-01-26 1981-01-26 Drug for digestive organ Granted JPS57126420A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP1065481A JPS57126420A (en) 1981-01-26 1981-01-26 Drug for digestive organ
JP41814490A JPH03246221A (en) 1981-01-26 1990-12-21 Rearing promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1065481A JPS57126420A (en) 1981-01-26 1981-01-26 Drug for digestive organ

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP41814490A Division JPH03246221A (en) 1981-01-26 1990-12-21 Rearing promoter

Publications (2)

Publication Number Publication Date
JPS57126420A true JPS57126420A (en) 1982-08-06
JPH0340010B2 JPH0340010B2 (en) 1991-06-17

Family

ID=11756204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1065481A Granted JPS57126420A (en) 1981-01-26 1981-01-26 Drug for digestive organ

Country Status (1)

Country Link
JP (1) JPS57126420A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
US4883672A (en) * 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
GB2230953A (en) * 1989-05-05 1990-11-07 Sigma Tau Ind Farmaceuti Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease
WO1991005554A1 (en) * 1989-10-23 1991-05-02 University Of Georgia Research Foundation, Inc. Carnitine supplemented cat fish diet
US5071874A (en) * 1989-06-14 1991-12-10 Lonza Ltd. L-carnitine magnesium citrate
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US5314689A (en) * 1988-05-26 1994-05-24 Attilio Bernardini Acyl-carnitine for the treatment and prevention of viral infections
US5362753A (en) * 1993-04-19 1994-11-08 Lonza Ltd. Method of increasing the hatchability of eggs by feeding hens carnitine
US6242487B1 (en) 1996-12-03 2001-06-05 Lonza, Inc. Carnitine supplemented diets for gestating and lactating swine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEM.ABSTR *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
US4883672A (en) * 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
US5314689A (en) * 1988-05-26 1994-05-24 Attilio Bernardini Acyl-carnitine for the treatment and prevention of viral infections
GB2230953A (en) * 1989-05-05 1990-11-07 Sigma Tau Ind Farmaceuti Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease
GB2230953B (en) * 1989-05-05 1993-03-24 Sigma Tau Ind Farmaceuti Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease
US5071874A (en) * 1989-06-14 1991-12-10 Lonza Ltd. L-carnitine magnesium citrate
WO1991005554A1 (en) * 1989-10-23 1991-05-02 University Of Georgia Research Foundation, Inc. Carnitine supplemented cat fish diet
US5030657A (en) * 1989-10-23 1991-07-09 University Of Georgia Research Foundation, Inc. L-carnitine supplemented catfish diet
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
WO1994001101A1 (en) * 1992-07-02 1994-01-20 Shug Austin L A method of treating reduced insulin-like growth factor and bone loss associated with aging
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US5362753A (en) * 1993-04-19 1994-11-08 Lonza Ltd. Method of increasing the hatchability of eggs by feeding hens carnitine
US6242487B1 (en) 1996-12-03 2001-06-05 Lonza, Inc. Carnitine supplemented diets for gestating and lactating swine

Also Published As

Publication number Publication date
JPH0340010B2 (en) 1991-06-17

Similar Documents

Publication Publication Date Title
KR920000324A (en) Essential Fatty Acid Treatment
ES2077530A1 (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
TNSN99163A1 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL-CARNITINE AND α -LIPOIC ACID WHICH IMPROVES THE METABOLIC USE OF GLUCOSE
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
RO116342B1 (en) Oral liquid pharmaceutical composition
GB9517443D0 (en) Increasing creatine and glycogen concentration in muscle
KR940018089A (en) Prevention and treatment for radiation damage of internal tissue
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
JPS57126420A (en) Drug for digestive organ
KR930000114A (en) Treatment with fatty acids
DE3751036T2 (en) Pharmaceutical substances directed by carnitine and their use in the manufacture of a medicament for the treatment of muscle disorders.
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
CA2386770A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
ATE184788T1 (en) COMPOSITIONS CONTAINING IDEBENONE FOR THE TREATMENT OF ALZHEIMER'S M
HK1009325A1 (en) Composition comprising l-carnitine or acyl-l-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
KR920702225A (en) Pharmaceutical composition
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
JPS57112331A (en) Medical composition of ganoderma lucidum component
GB2258397A (en) Pharmaceutical compositions containing amethocaine
DE68910010D1 (en) Use of dapiprazole in the manufacture of a medicament for preventing tolerance development in analgesic treatment with morphine.
IL101908A (en) Process for extraction of antineoplastic substances from plants of the family pittosporaceae, extracts obtained thereby, and pharmaceutical preparations containing them
CA2103707A1 (en) Treatment of non-small cell lung carcinoma
Kiesel et al. Prevention of diabetes in BB rats by an E. coli extract(OM-89)